These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8355812)

  • 21. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
    Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
    Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
    Blennow K; Bogdanovic N; Alafuzoff I; Ekman R; Davidsson P
    J Neural Transm (Vienna); 1996; 103(5):603-18. PubMed ID: 8811505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
    Lemere CA; Oh J; Stanish HA; Peng Y; Pepivani I; Fagan AM; Yamaguchi H; Westmoreland SV; Mansfield KG
    Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly.
    Zhan SS; Veerhuis R; Kamphorst W; Eikelenboom P
    Neurodegeneration; 1995 Sep; 4(3):291-7. PubMed ID: 8581561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
    Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.
    Zhan SS; Kamphorst W; Van Nostrand WE; Eikelenboom P
    Acta Neuropathol; 1995; 89(4):356-62. PubMed ID: 7610767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition.
    Yamaguchi H; Ishiguro K; Sugihara S; Nakazato Y; Kawarabayashi T; Sun X; Hirai S
    Acta Neuropathol; 1994; 88(5):413-9. PubMed ID: 7847069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
    Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
    Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
    Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
    Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A beta 40 and the A beta that ends at residues alanine42/threonine43 (A beta 42).
    Akiyama H; Mori H; Sahara N; Kondo H; Ikeda K; Nishimura T; Oda T; McGeer PL
    Neurochem Res; 1997 Dec; 22(12):1499-506. PubMed ID: 9357016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.